Career Center



  The Ten Mistakes That Senior Management Teams Make with Investigational New Drug Applications
Date:   Tuesday, March 2, 2010
Time:   12:00 - 2:00 PM

The San Jose BioCenter
5941 Optical Court
San Jose, CA 95138

Sponsor:   The San Jose BioCenter
Event details:  

The achievement of a cleared Investigational New Drug application (IND) is a critical milestone for most small to mid-sized companies. Senior Management teams face many challenges when working on these applications. These are not easy applications to create, and there are many potential pitfalls.

During this presentation the pitfalls that CEOs and senior management teams need to be aware of will be identified. A panel session will follow the main presentation at which time the audience will be able to address questions to members of the panel.

Webinar link-up is available for those who are not able to participate on-site. Please indicate if you would like to join by webinar when signing up. The details for the webinar will be sent to participants before the event.

• Panel Chair: Debra Gosling, Account Executive, Regulatory & Clinical Services, Liquent Inc.
• Lead Speaker: Lorna Speid, M.R.Pharm.S., Ph.D., RAC., President, Speid & Associates, Inc.
• Sarah Powell, Executive Director of Regulatory Strategies, Liquent Inc.
• Jim Hilferty, Operations Manager, Regulatory & Clinical Services, Liquent Inc.

Additional information and/or registration:  

Space is limited for this event, so early pre-registration is recommended to avoid disappointment on the day!
Pre-registration closes on Feb 26 at 5pm!

Face to face Registration:
• Regular Price*: $30
• Partners' Network*: $20
• BioCenter Members*: Free (please RSVP to Aurélie)
• On-site Registration: add $10 to the above
* includes lunch

Webinar Registration:
• Regular Price: $20
• Partners' Network: $15

Register online

Footer Links: